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The glycoproteins recognized by monoclonal an­
tibody (MAb)  NKI-beteb a re  among the best diag­
nostic m arkers f o r  human melanoma. MAb NKI- 
beteb reacts w ith melanoma cells throughout 
tum or developm ent and does not cross-react with  
other tum or o r  norm al cells, ex cep tfo r  cells o f  the 
melanocylic lineage. Two other melanocyte
MAbs, HMB-50 and HMB-45,
show  a  specificity and staining pa ttern  strikingly 
sim ilar to the ones observed f o r  NKI-beteb. 
Herein, u>e dem onstrate that all three MAbs rec­
ognize p ro te in  p ro d u c ts  encoded by a single 
cDNA. E xpression  o f  this cDNA in BLM cells re ­
sults in im m unoreactivity w ith all three MAbs. In 
addition, w e dem onstrate co-distribution o f  the
RNA
Hon
species detected  by the cDNA with the p r o ­
teins recognized by the MAbs in tissue sections.
(Am f  Pathol 1993, 143:1579-1585)
The melanocyte lineage-specific antigens recog­
nized by monoclonal antibody (MAb) NKI-beteb are 
among the best diagnostic markers for human mela­
noma available to date.1 MAb NKI-betefo reacts with
1
melanoma ceils throughout tumor development; it 
stains nevocellular nevi, primary cutaneous and uveal 
melanoma, melanoma métastasés, and melanoma of 
soft tissues.1,2 MAb NKI-beteb does not cross-react 
with other tumor cell types or normal cells, except for 
cells of the melanocytic lineage. The antigens rec­
ognized by MAb NKI-beteb are glycoproteins of 100 
kd (gp100) and 7 kd (gp7), which are localized at the 
innerside of premelanosomal vesicles.1 Gp100 has 
also been detected in growth medium of melanoma 
cells cultured in vitro.
Two other MAbs, HMB-45 and HMB-50, have 
been described that show a specificity and staining 
pattern very similar to the ones observed for MAb 
NKI-beteb.3,4 MAb HMB-50 identifies a glyco­
sylated, intracellular protein of 95 kd that is re­
leased into the growth medium by melanoma cells 
and neonatal melanocytes in vitro.4 In addition, 
MAb HMB-50 immunoprecipitates a 10 kd protein 
from melanoma-cell extracts.4 The antigen recog­
nized by MAb HMB-45 localizes in premelanosomal 
vesicles5 and has been suggested to have a mo­
lecular weight of 10 kd.6 In contrast to MAb NKI- 
beteb, neither of these MAbs react with resting 
adult melanocytes.3'4
Despite their importance in diagnostic pathology 
of malignant melanoma, the primary structure of the 
melanocyte lineage-specific antigens recognized 
by each of these MAbs remains undefined. Herein,
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we report the isolation of a cDNA, which not only 
encodes the antigens recognized by MAb NKI- 
beteb, but also those recognized by MAbs HMB-45 
and HMB-50.
using calcium phosphate transfection systems 
(Bethesda Research Laboratories, Bethesda, MD). 
Five hours after the addition of the precipitate cells 
were shocked with either dimethylsulfoxide (10% in 
medium for 90 seconds) or glycerol (10% in me-
Materials and Methods
dium for 3 minutes). Forty-eight hours after transfec­
tion cells were prepared for immunofluorescence
Cells and Tissues
(fluorescein isothiocyanate) as described previ­
ously.1 MAbs NKI-beteb and HMB-50 were de-
The melanoma cell lines MEL-2a, MEL-1, M14, 
MEL-57, MEWO, and BLM were described 
previously.1,4,7' 10 Isolation of normal human mela­
nocytes from breast or foreskin was performed by
scribed previously.1-'1 MAb HMB-45 was purchased 
from Enzo Biochem. Preparations were examined 
on a confocal laser scanning microscope at 488 nm 
(Bio-Rad MRC 600).
the method of Eisinger and Marko11 with modifica-
tions as described previously.12,13 Normal fetal epi­
dermal tissue (approximately 15 weeks) and three 
primary cutaneous melanomas were obtained after
immunocytochemistry and In Situ 
Hybridization
surgery and immediately frozen in liquid nitrogen 
until use.
For immunocytochemistry, serial cryosections (5 p) 
were fixed in acetone (10 minutes) then rehydrated
and incubated with MAbs NKI-beteb (Zymed Labo-
cDNA Library Construction, Screening, 
and Subcloning
ratories, 1:150), HMB-45 (ENZO Biochem, 1:80), or 
HMB-50 ascites (1:1000) for 1 hour at 20°C. Subse­
quently, sections were washed then incubated with
A A-gt11 cDNA expression library was constructed 
from poly(A)'1' RNA isolated from the human mela­
noma cell line MEL-1 and screened with the rabbit
biotinylated horse anti-mouse antiserum (Vector, 
1:200) for 30 minutes at 37°C then washed again 
and incubated with an avidin-biotin-peroxidase
polyclonal antiserum against the 95 kd glycopro­
tein4 using standard techniques.14 The cDNA insert 
of a positive clone, A-gp100-c1, was removed as an
EcoRI fragment, blunt-ended by filling in the ends 
with Klenow DNA polymerase and then ligated in 
the Sma I site of pRSV328A15 in either the coding 
(pRSVgp100+) or the noncoding (pRSVgp100-) 
orientation.
complex (Vector, 1:100) for 30 minutes at 37“C. The 
immunohistochemical reaction was visualized with 
amino-ethyl-carbazole/H20 H. Finally, the sections 
were counterstained with hematein and embedded 
in Kaiser's glycerin. Cryosections not incubated with 
a primary MAb served as a control,
RNA in situ hybridization was performed on cryo­
sections (8 (j) adjacent to those used for immunocy-
tochemistry as described earlier.114,10 As a probe we
RNA Isolation and Northern Blot Analysis
used a « - p ’Sj-dCTP random primed labeled EcoRI- 
Nco I fragment (± 550 bp) of gp100-c1 cDNA. As a
Total RNA was prepared by the guanidine thiocya- 
nate procedure and centrifugation through a cush­
ion of cesium chloride.16 RNA samples (5 to 30 jjg) 
were size fractionated on a formaldehyde-agarose 
gel, transferred onto Hybond-N membranes (Amer-
control, cryosections were hybridized to a-[a‘'S] ran­
dom primed labeled phage A-DNA,
Results
sham), and hybridized to a-[32P]-dATP-labeled 
probes (random primed DNA labeling kit, Boeh-
ringer Mannheim, Mannheim, Germany). As probes
i
we have used the 5' EcoR\-Nco I fragment (±550 
bp) or the 3' 0s/XI-£coRI fragment (±450 bp) of 
gp100-c1 cDNA.
Based on the immunohistochemical and biochemi­
cal data described above, we assumed that the 
gp100 antigen recognized by MAb NKI-beteb and 
the 95 kd glycoprotein recognized by MAb HMB-50 
share a similar, if not identical protein backbone. 
Therefore, we used a rabbit polyclonal antiserum
against the 95 kd glycoprotein to screen a A-gt11
Transfection and Immunofluorescence
BLM cells were transfected with 20 (jg of DNA by 
the calcium phosphate co-precipitation procedure17
cDNA expression library prepared from poly(A)1 
RNA isolated from human melanoma cells.4 A posi­
tive clone, A-gp100-c1, containing a cDNA insert of
approximately 2.2 kb was obtained and used for
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further analysis. To detect the RNA species from 
which the cDNA is derived, Northern blot analysis 
was performed using either the 5' part (± 550 bp) 
or the 3' part (± 450 bp) of gp100-c1 cDNA as a 
probe. Both probes specifically detected RNA spe­
cies of 2.5 kb, 4.2 kb, and a high molecular weight 
RNA species (>15 kb) in total RNA isolated from 
adult and neonatal melanocytes as well as in total 
RNA isolated from four of five human melanoma 
cells (Figure 1 and results not shown). The same 
RNA species were detected in poly(A)+ RNA iso­
lated from human melanoma cells (not shown). Note 
that no hybridizing RNA species were detected in 
RNA from BLM melanoma cells, consistent with the 
absence of reactivity with the MAbs (see below).
GP100-C1 cDNA Encodes a Protein that 
is Recognized by MAbs NKI-beteb, 
HMB-50, and HMB-45
To determine whether gp100-c1 cDNA encodes the 
antigen recognized by MAbs NKI-beteb and/or 
HMB-50, we cloned the cDNA into the eukaryotic 
expression vector pRSV328A15 in either the coding 
(pRSVgp100+) or the noncoding (pRSVgplOO-) 
orientation and transfected these constructs in BLM 
melanoma cells. BLM cells were selected for the
>15
4.2
2.5
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Figure 1. RNA species detected by gplOO-cl cDNA in cells of the me- 
lanocytic lineage. Northern blot analysis o f total RNA isolated from  
adult (lane 1) and neonatal (lane 4) melanocytes as well as from  
five different melanoma cell lines (BLM, lane 2, ME WO, lane 3, MEL- 
2a, lane 5, MEL-57, lane 6, andM14, lane 7). Tloe Northern blot was 
hybridized to the 5r Eco/?/-Nco 1 fragment o f gplOO-cl cDNA. The 
size (kb) and position o f the hybridizing RNA species are indicated by 
an arrow. The same results were obtained using the 3' Bst XI-EcoRI 
fragment o f gplOO-cl cDNA as a probe (not shown).
transfection experiments, because they do not react 
with MAbs NKI-beteb, HMB-50, or HMB-45 nor ex­
press the RNA species detected by the gp100-c1 
cDNA probe (see above). As shown in Figure 2 B 
and H, BLM cells expressing the transcription unit 
containing the cDNA in the coding orientation re­
acted with MAb NKI-beteb and MAb HMB-50. The 
granular, cytoplasmic staining pattern observed 
with MAbs NKI-beteb and HMB-50 in the trans­
fected cells is very similar to the one observed in 
MEWO melanoma cells, which express the antigens 
endogenously (Figure 2 A and G). No ¡mmunoreac- 
tivity to either MAb was observed when BLM 
cells were transfected with the construct containing 
the cDNA in the noncoding orientation (Figure 2 C 
and I).
The similar reactivity of MAbs NKI-beteb and 
HMB-45 to cells of the melanocytic lineage led us to 
investigate whether MAb HMB-45 reacts with the 
proteins encoded by gp100-c1 cDNA. As shown in 
Figure 2 E and F, only BLM cells transfected with 
pRSVgp100+ reacted with MAb HMB-45. The stain­
ing pattern observed with MAb HMB-45 in trans­
fected BLM cells was similar to the one observed 
with MAbs NKI-beteb and HMB-50 and mimicked 
the one of HMB-45-stained MEWO melanoma cells 
(Figure 2 B, D, E, and H). We conclude from these 
data that a single cDNA encodes the melanocyte 
lineage-specific antigens recognized by MAbs NKI- 
beteb, HMB-50, and HMB-45.
In Situ Detection of GP100 RNA and 
Protein in Malignant Melanomas and 
Fetal Skin
Because of their specificity for cells of the melano­
cytic lineage MAbs NKI-beteb, HMB-45, and HMB-50 
are important tools in the diagnosis of malignant mela­
noma. To compare the distribution of the proteins rec­
ognized by these MAbs with the expression pattern of 
the RNA species detected by gp100-c1 cDNA, we 
performed in situ hybridization in combination with 
immunocytochemistry on sequential cryosections of 
primary melanomas and fetal skin. In two primary 
melanomas co-distribution of gp100 RNA and the 
proteins recognized by each of the MAbs was ob­
served (Figure 3). Beside melanocytes and/or mela­
noma cells, no other cells reacted with the cDNA
■
probe or the MAbs. One other primary melanoma we 
selected as a control did not react with any of the 
MAbs nor with the cDNA probe (not shown). This re­
sult demonstrates that for the tumor biopsies the pres­
ence or absence of reactivity with all three MAbs and
II
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Figure 2. Expression o f the cDNA clone in BLM cells transfers immunoreactivity to MAbs NKI-beteb, HMB-45, and HMB-50, BLM cells transfected 
with either pRSVgpl 00+ (B, E, H) or pRSVgp 100- (C, F, I) and MEWO cells (A, D, G) were analyzed fo r  reactivity to MAbs NKI-beteb (A to C), 
HMB-45 (D to F), or HMB-50 (G to i). Indirect immunofluorescence (fluorescein isothiocyanate) was examined by confocal laser scanning mi­
croscopy. Magnification is indicated by a size bar (25 pi) in A.
with gp100-c1 cDNA are mutually exclusive. Co­
distribution of RNA and protein in fetal skin was most 
pronounced in melanocytes present in hair follicles 
(not shown). Hair follicles cut at a position devoid of 
melanocytes did not react with the cDNA probe or the
MAbs (not shown). Taken together, these results 
clearly demonstrate specific co-distribution of RNA 
species detected by gp100-c1 cDNA with the pro­
teins recognized by all three MAbs in cells of the me- 
lanocytic lineage.
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MAb HMB-45,3 which is widely used in diagnostic 
pathology because of its specificity and sensitivity 
on paraffin-embedded tissue sections, also reacts 
with BLM cells expressing gp100-c1 cDNA. This re­
sult is consistent with previous data suggesting that 
MAbs NKI-beteb and HMB-45 recognize different 
epitopes on the same antigen.1
An RNA species of 2.5 kb is the major RNA prod­
uct detected by the cDNA probe in melanoma cells 
as well as in adult and neonatal skin melanocytes. 
In these cells, additional RNA species of 4.2 and 
>15 kb were also discerned. The finding that the 5' 
part and the 3' part of gp100-c1 cDNA detect the 
same RNA species indicates that the cDNA isolated 
is derived from a single RNA species. The size of 
the major polyadenylated RNA species detected 
(2.5 kb) is also consistent with the size of gp100-c1 
cDNA (2.2 kb). Using in situ hybridization in combi­
nation with immunocytochemistry on sequential 
sections of primary melanomas and fetal skin, we 
demonstrate co-distribution of gp100 RNA with pro­
teins reacting to all three MAbs in cells of the mela- 
nocytic lineage. These findings provide additional 
evidence that gp100-c1 cDNA encodes the anti­
gens recognized by all three MAbs. The notion that 
the melanocyte lineage-specific antigens recog­
nized by MAbs NKI-beteb, HMB-50, and HMB-45 
are encoded by a single cDNA is also fully consis­
tent with the finding that proteins of 100 and 10 kd 
are immunoprecipitated by MAbs NKI-beteb and 
HMB-50 from nonpigmented COS cells expressing 
gp100-c1 cDNA (G.J. A. et al, manuscript submit­
ted).
Comparison of the reported reactivity of MAbs 
NKI-beteb, HMB-45, and HMB-50 to subpopula­
tions of melanocytic cells reveals that all three 
MAbs react with melanoma cells and neonatal and 
fetal melanocytes, but that only MAb NKI-beteb rec­
ognizes resting adult melanocytes in skin.1,3,4 This 
observation led to the hypothesis that MAbs 
HMB-50 and HMB-45 detect oncofetal proteins.3,4 
However, the finding that all three MAbs recognize 
the protein encoded by a single cDNA argues 
against this hypothesis and suggests a role for 
posttranslational protein modification. Aberrations in 
posttranslational modification (ie, glycosylation) of 
proteins are known to frequently occur in tumor 
cells, including melanoma cells.20 Actually, differ­
ences in the posttranslational modification of the an­
tigens detected by HMB-50 in melanoma cells com­
pared with neonatal foreskin melanocytes have 
been reported.4 In addition, results of a recent 
study suggest that the epitope recognized by MAb
HMB-45 is dependent on the presence of sialated 
glycoconjugates.21 Furthermore, we found that cul­
tured adult melanocytes strongly react with all three 
MAbs (not shown).13 This latter result is consistent 
with previous data showing that beside neoplastic 
transformation, melanocyte stimulation also results 
in immunoreactivity to MAb HMB-45.22,23 Collec­
tively, these data implicate that MAbs HMB-45 and 
HMB-50 recognize posttranslational modifications 
of a constitutively expressed melanocyte-specific 
protein, not a de novo synthesized oncofetal pro­
tein.
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